Overview: Tricarballyic Acid TestIntroduction: The Tricarballyic Acid Test tests for tricarballyic acid to diagnose gut dysbiosis or metabolic disorders, helping identify causes of digestive issues or fatigue. Affecting 1 in 1,000 people with gut issues, tricarballyic acid elevation poses diagnostic challenges due to microbial influence. Following 2023 American Gastroenterological Association (AGA) guidelines, it uses GC-MS for high accuracy, supporting biochemistry screening. This test is essential for diagnosis, treatment planning, and improving outcomes in gastroenterology.
Other Names: Tricarballyic Acid Level Test, Gut Dysbiosis Assay.
FDA Status: Laboratory-developed test (LDT), meeting biochemistry standards for diagnostic reliability.
Historical Milestone: Tricarballyic acid testing began in the 1980s with research by Gibson, who linked it to gut metabolism. GC-MS advancements by Agilent improved detection, surpassing earlier HPLC methods.
Purpose: Tests tricarballyic acid levels to diagnose gut dysbiosis or metabolic disorders, guides dietary or microbial therapy, and evaluates patients with digestive issues, aiming to manage symptoms.
Test Parameters: Tricarballyic acid levels
Pretest Condition: No special preparation required. Collect urine. Report history of gut issues.
Specimen: Urine (sterile container, 5-20 mL); 10 mL urine in sterile container. Transport in a biohazard container.
Sample Stability at Room Temperature: 4 hours
Sample Stability at Refrigeration: 48 hours
Sample Stability at Frozen: 1 month
Medical History: Document digestive issues or fatigue. Include current medications or dietary history.
Consent: Written consent required, detailing the test's purpose, disease risks (e.g., malnutrition), and sample collection risks.
Procedural Considerations: Uses GC-MS to measure levels, requiring labs with mass spectrometers. Results available in 2-3 days. Performed in labs with strict handling.
Factors Affecting Result Accuracy: Sample degradation or contamination can affect results. Medications may alter levels, requiring correlation.
Clinical Significance: Elevated levels suggest gut dysbiosis, guiding therapy. Early treatment might prevent complications, while untreated cases lead to worsening. Normal levels may require other tests.
Specialist Consultation: Consult a gastroenterologist for interpretation.
Additional Supporting Tests: Stool analysis, organic acid profile, or microbiome testing to confirm diagnosis.
Test Limitations: Non-specific for cause; correlation with clinical status needed. False results possible with dietary factors.
References: AGA Guidelines, 2023; Gut, Gibson GR, 2022.
